Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model
-
Published:2022-05
Issue:
Volume:19
Page:101378
-
ISSN:1936-5233
-
Container-title:Translational Oncology
-
language:en
-
Short-container-title:Translational Oncology
Author:
Tobias Joshua,
Drinić Mirjana,
Högler Sandra,
Ambroz Katharina,
Baier Karin,
Kodajova Petra,
Tomasich Erwin,
Berghoff Anna S.,
Schmid Anna,
Garner-Spitzer Erika,
Kenner Lukas,
Kundi MichaelORCID,
Zielinski Christoph C.,
Wiedermann Ursula
Subject
Cancer Research,Oncology
Reference37 articles.
1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
2. The role of HER2 in cancer therapy and targeted drug delivery;Tai;J. Control Release,2010
3. Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies;Witsch;Int. Immunol.,2011
4. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study;Swain;Lancet Oncol.,2020
5. Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update;Giordano;J. Clin. Oncol.,2018
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献